Claims
- 1. A non-irritating anti-viral lotioned tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising:
a virucidal effective amount of at least one anti-viral organic acid; a topical delivery system including at least one polyester.
- 2. The lotioned tissue product of claim 1, wherein said lotion composition comprises from about 1% to about 25% of said anti-viral organic acid.
- 3. The lotioned tissue product of claim 2, wherein said at least one anti-viral organic acid comprises at least one member from the group consisting of carboxylic acids having the structure R—COOH, wherein R is a C1-C6 alkyl; C1-C6 alkyl carboxy; C1-C6 alkyl carboxyhydroxy; C1-C6 alkyl carboxy halo; C1-C6 alkylcarboxy dihydroxy; C1-C6 alkyl dicarboxyhydroxy; C1-C6 alkenyl; C1-C6 alkenyl carboxy; C1-C6 alkenyl phenyl; or substituted phenyl radical.
- 4. The lotioned tissue product of claim 3, wherein one or more hydrogen atoms of R is substituted with a functional group selected from the group consisting of halogen atoms, hydroxyl groups, amino groups, thiol groups, nitro groups, and cyano groups.
- 5. The lotioned tissue product of claim 3, wherein said at least one anti-viral acid is selected from the group consisting of citric acid, malic acid, adipic acid, glutaric acid, succinic acid, and mixtures thereof.
- 6. The lotioned tissue product of claim 2, wherein said at least one polyester comprises a hydroxy-functional polyester diol.
- 7. The lotioned tissue product of claim 6, wherein said at least one polyester comprises trimethylpentanediol/adipic acid copolymer.
- 8. The lotioned tissue product of claim 2, wherein said at least one polyester comprises a fatty alkyl capped complex polyester.
- 9. The lotioned tissue product of claim 8, wherein said at least one polyester comprises trimethylpentanediol/adipic isononanoic acid copolymer
- 10. The lotioned tissue product of claim 1, wherein the lotion composition further comprises a surfactant.
- 11. A lotioned tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising:
about 1% to about 25% of at least one anti-viral organic acid; about 5% to about 25% of an emollient including at least one polyester; and a cationic surfactant.
- 12. The lotioned tissue product of claim 11, wherein said emollient comprises at least one polyester from the group consisting of fatty alkyl capped complex polyesters, hydroxy-functional polyester diols, and mixtures thereof.
- 13. The lotioned tissue product of claim 11, wherein said cationic surfactant comprises a quaternary ammonium compound.
- 14. A non-irritating, anti-viral lotion composition comprising:
a virucidal effective amount of at least one anti-viral organic acid; and a topical delivery system including at least one polyester.
- 15. The lotion composition of claim 14, wherein said lotion composition comprises from about 1% to about 25% of said anti-viral organic acid.
- 16. The lotion composition of claim 15, wherein said at least one anti-viral organic acid comprises at least one member from the group consisting of carboxylic acids having the structure R—COOH, wherein R is a C1-C6 alkyl; C1-C6 alkyl carboxy; C1-C6 alkyl carboxyhydroxy; C1-C6 alkyl carboxy halo; C1-C6 alkylcarboxy dihydroxy; C1-C6 alkyl dicarboxyhydroxy; C1-C6 alkenyl; C1-C6 alkenyl carboxy; C1-C6 alkenyl phenyl; or substituted phenyl radical.
- 17. The lotion composition of claim 16, wherein one or more hydrogen atoms of R is substituted with a functional group selected from the group consisting of halogen atoms, hydroxyl groups, amino groups, thiol groups, nitro groups, and cyano groups.
- 18. The lotion composition of claim 16, wherein said at least one anti-viral acid is selected from the group consisting of citric acid, malic acid, adipic acid, glutaric acid, succinic acid, and mixtures thereof.
- 19. The lotion composition of claim 15, wherein said at least one polyester comprises a hydroxy-functional polyester diol.
- 20. The lotion composition of claim 19, wherein said at least one polyester comprises trimethylpentanediol/adipic acid copolymer.
- 21. The lotion composition of claim 15, wherein said at least one polyester comprises a fatty alkyl capped complex polyester.
- 22. The lotion composition of claim 21, wherein said at least one polyester comprises trimethylpentanediol/adipic isononanoic acid copolymer
- 23. The lotion composition of claim 14, wherein the lotion composition further comprises a surfactant.
- 24. The lotion composition of claim 23, wherein said surfactant comprises a cationic surfactant.
- 25. A anti-viral lotion composition comprising:
about 1% to about 25% of at least one anti-viral organic acid; about 5% to about 25% of an emollient including at least one polyester; and a cationic surfactant.
- 26. The lotion composition of claim 25, wherein said emollient comprises at least one polyester from the group consisting of fatty alkyl capped complex polyesters, hydroxy-functional polyester diols, and mixtures thereof.
- 27. The lotion composition of claim 26, wherein said cationic surfactant comprises a quaternary ammonium compound.
- 28. A method of inhibiting the transfer of a viral infection comprising:
providing anti-viral lotion tissue product having applied to at least one surface thereof an anti-viral lotion composition comprising a virucidal effective amount of at least one anti-viral organic acid and a topical delivery system including at least one polyester; contacting a fluid containing at least one virus with said anti-viral tissue product; and absorbing said fluid within said absorbent article to contact the fluid with said anti-viral lotion composition.
- 29. The method of claim 28, further comprising:
transferring a portion of the lotion composition to the user of the tissue product.
- 30. The method of claim 28, wherein said at least one polyester comprises a hydroxy-functional polyester diol.
- 31. The method of claim 28, wherein said at least one polyester comprises a fatty alkyl capped complex polyester.
- 32. A method of making an anti-viral tissue product comprising:
heating a composition comprising an a virucidal effective amount of at least one anti-viral organic acid at least one polyester, at least one oil and at least one wax to a temperature above the melting point of the composition, causing said composition to melt, said composition having a melting point of from about 30° C. to about 70° C.; uniformly applying the melted composition to at least one surface of a tissue web in spaced-apart deposits; and resolidifying the deposits of the melted composition.
- 33. The method of claim 32 wherein the heated composition is applied to the tissue web with a gravure printer.
- 34. The method of claim 32 wherein the tissue web is cooled before or after the deposits of the coating composition are applied in order to accelerate solidification of the deposits.
- 35. The method of claim 32 wherein the tissue product is a facial tissue.
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. App. Ser. No. 60/173,830, entitled, “Anti-Viral Lotion Tissue, and Methods for Making and Using the Same,” filed Dec. 30, 1999, the entire disclosure of which is incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60173830 |
Dec 1999 |
US |